Atea Pharmaceuticals (AVIR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.32, -4.64% vs the prior close of $4.53.
- Volume 345.81K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AVIR slides 4.6% to $4.32, a 3-month low, 6 down days in a row. Closed at $4.32, -4.64% vs the prior close of $4.53. Day range $4.30–$4.55, opened at $4.54.
AVIR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AVIR slides 4.6% to $4.32, a 3-month low, 6 down days in a row
- Closed at $4.32, -4.64% vs the prior close of $4.53. Day range $4.30–$4.55, opened at $4.54.
- Volume was 345.81K shares, 1.3x its 50-day average of 270.61K.
- Price is -17.6% vs its 50-day average ($5.24) and -11.7% vs its 200-day average ($4.89).
- 52-week range $2.87–$6.45; today's close sits at 41% of that range, 33.0% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — AVIR dips 2.2% to $4.53, a 1-month low, 5 down days in a row
- Closed at $4.53, -2.16% vs the prior close of $4.63. Day range $4.48–$4.80, opened at $4.64.
- Volume was 319.40K shares, 1.2x its 50-day average of 269.40K.
- Price is -13.8% vs its 50-day average ($5.26) and -7.4% vs its 200-day average ($4.89).
- 52-week range $2.87–$6.45; today's close sits at 46% of that range, 29.8% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — AVIR slides 7.0% to $4.63, a 1-month low, 4 down days in a row
- Closed at $4.63, -7.03% vs the prior close of $4.98. Day range $4.60–$4.92, opened at $4.92.
- Volume was 414.50K shares, 1.5x its 50-day average of 269.24K.
- Price is -12.0% vs its 50-day average ($5.26) and -5.2% vs its 200-day average ($4.89).
- 52-week range $2.87–$6.45; today's close sits at 49% of that range, 28.2% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — AVIR dips 1.0% to $4.98, a 1-month low, 3 down days in a row
- Closed at $4.98, -0.99% vs the prior close of $5.03. Day range $4.87–$5.04, opened at $5.03.
- Volume was 303.20K shares, 1.1x its 50-day average of 267.78K.
- Price is -5.4% vs its 50-day average ($5.26) and +2.0% vs its 200-day average ($4.88).
- 52-week range $2.87–$6.45; today's close sits at 59% of that range, 22.8% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — AVIR dips 2.3% to $5.03
- Closed at $5.03, -2.33% vs the prior close of $5.15. Day range $5.03–$5.20, opened at $5.13.
- Volume was 190.70K shares, 0.7x its 50-day average of 273.40K.
- Price is -4.3% vs its 50-day average ($5.25) and +3.2% vs its 200-day average ($4.87).
- 52-week range $2.87–$6.45; today's close sits at 60% of that range, 22.0% below the 52-week high.
Oct 9, 2026 — AVIR ends flat (-0.1%) to $5.15
- Closed at $5.15, -0.10% vs the prior close of $5.16. Day range $5.09–$5.23, opened at $5.15.
- Volume was 158.00K shares, 0.6x its 50-day average of 281.51K — lighter than usual.
- Price is -1.9% vs its 50-day average ($5.25) and +5.8% vs its 200-day average ($4.87).
- 52-week range $2.87–$6.45; today's close sits at 64% of that range, 20.2% below the 52-week high.
Oct 8, 2026 — AVIR rises 2.9% to $5.16
- Closed at $5.16, +2.89% vs the prior close of $5.01. Day range $4.91–$5.23, opened at $4.98.
- Volume was 350.90K shares, 1.2x its 50-day average of 289.33K.
- Price is -1.6% vs its 50-day average ($5.24) and +6.2% vs its 200-day average ($4.86).
- 52-week range $2.87–$6.45; today's close sits at 64% of that range, 20.1% below the 52-week high.
Oct 7, 2026 — AVIR dips 1.2% to $5.01, a 1-month low, 3 down days in a row
- Closed at $5.01, -1.18% vs the prior close of $5.07. Day range $4.99–$5.23, opened at $5.02.
- Volume was 264.80K shares, 0.8x its 50-day average of 311.89K.
- Price is -4.2% vs its 50-day average ($5.23) and +3.4% vs its 200-day average ($4.85).
- 52-week range $2.87–$6.45; today's close sits at 60% of that range, 22.3% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — AVIR dips 1.2% to $5.07, a 1-month low
- Closed at $5.07, -1.17% vs the prior close of $5.13. Day range $4.98–$5.19, opened at $5.16.
- Volume was 229.40K shares, 0.7x its 50-day average of 313.59K.
- Price is -2.9% vs its 50-day average ($5.22) and +4.8% vs its 200-day average ($4.84).
- 52-week range $2.84–$6.45; today's close sits at 62% of that range, 21.4% below the 52-week high.
Oct 5, 2026 — AVIR ends flat (+0.0%) to $5.13
- Closed at $5.13, +0.00% vs the prior close of $5.13. Day range $4.95–$5.18, opened at $5.12.
- Volume was 293.60K shares, 0.9x its 50-day average of 315.34K.
- Price is -1.6% vs its 50-day average ($5.21) and +6.3% vs its 200-day average ($4.83).
- 52-week range $2.81–$6.45; today's close sits at 64% of that range, 20.5% below the 52-week high.
Oct 2, 2026 — AVIR rises 0.6% to $5.13
- Closed at $5.13, +0.59% vs the prior close of $5.10. Day range $5.05–$5.22, opened at $5.16.
- Volume was 253.30K shares, 0.8x its 50-day average of 313.91K.
- Price is -1.5% vs its 50-day average ($5.21) and +6.5% vs its 200-day average ($4.82).
- 52-week range $2.78–$6.45; today's close sits at 64% of that range, 20.5% below the 52-week high.
AVIR latest news & SEC filings
Every SEC filing by or about AVIR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$32.93M (prior year -$37.16M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.41 (prior year -$0.44) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade AVIR
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 5, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.05% (largest 7.0%).
- Liquidity: about 289.24K shares (≈$1.25M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.32 vs a range of $2.87–$6.45 (41% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Polly A. Murphy bought 6,100 shares on May 18, 2026.
- Latest filings: 10-Q Aug 12, 2026; 8-K Aug 12, 2026; 8-K Jun 22, 2026.
- Share count: 80.20M shares outstanding (Aug 10, 2026), +1.1% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AVIR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.54 | 4.55 | 4.30 | 4.32 | 345.81K |
| Oct 15, 2026 | 4.64 | 4.80 | 4.48 | 4.53 | 319.40K |
| Oct 14, 2026 | 4.92 | 4.92 | 4.60 | 4.63 | 414.50K |
| Oct 13, 2026 | 5.03 | 5.04 | 4.87 | 4.98 | 303.20K |
| Oct 12, 2026 | 5.13 | 5.20 | 5.03 | 5.03 | 190.70K |
| Oct 9, 2026 | 5.15 | 5.23 | 5.09 | 5.15 | 158.00K |
| Oct 8, 2026 | 4.98 | 5.23 | 4.91 | 5.16 | 350.90K |
| Oct 7, 2026 | 5.02 | 5.23 | 4.99 | 5.01 | 264.80K |
| Oct 6, 2026 | 5.16 | 5.19 | 4.98 | 5.07 | 229.40K |
| Oct 5, 2026 | 5.12 | 5.18 | 4.95 | 5.13 | 293.60K |
| Oct 2, 2026 | 5.16 | 5.22 | 5.05 | 5.13 | 253.30K |
| Oct 1, 2026 | 5.16 | 5.20 | 4.93 | 5.10 | 408.70K |
| Sep 30, 2026 | 5.20 | 5.29 | 5.14 | 5.21 | 296.30K |
| Sep 29, 2026 | 5.20 | 5.23 | 5.08 | 5.18 | 298.30K |
| Sep 28, 2026 | 5.15 | 5.30 | 5.10 | 5.20 | 238.40K |
| Sep 25, 2026 | 5.16 | 5.21 | 5.04 | 5.17 | 280.70K |
| Sep 24, 2026 | 5.28 | 5.30 | 5.14 | 5.17 | 228.80K |
| Sep 23, 2026 | 5.60 | 5.60 | 5.25 | 5.28 | 232.30K |
| Sep 22, 2026 | 5.46 | 5.66 | 5.38 | 5.64 | 237.50K |
| Sep 21, 2026 | 5.36 | 5.52 | 5.32 | 5.43 | 440.10K |
About Atea Pharmaceuticals
Atea Pharmaceuticals (AVIR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOSTON, MA. State of incorporation: MA. Fiscal year ends December 31. SEC CIK 1593899.
AVIR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jerome M. Adams | Director | Jun 23, 2026 |
| Franklin M Berger | Director | Jun 23, 2026 |
| Howard Berman | Director | Jun 23, 2026 |
| Barbara Gayle Duncan | Director | Jun 23, 2026 |
| Arthur S Kirsch | Director | Jun 23, 2026 |
| Bruno Lucidi | Director | Jun 23, 2026 |
| Polly A. Murphy | Director | Jun 23, 2026 |
| Bruce Polsky | Director | Jun 23, 2026 |
| Jean-Pierre Sommadossi | President, CEO, and Chairman | Feb 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Andrea Corcoran | See Remarks | Mar 13, 2026 |
| Wayne Foster | EVP, Chief Accounting Officer | Feb 3, 2026 |
| Janet Mj Hammond | Chief Development Officer | Feb 3, 2026 |
| Maria Arantxa Horga | Chief Medical Officer | Feb 3, 2026 |
| Jean-Pierre Sommadossi | President, CEO, and Chairman | Feb 3, 2026 |
| John Vavricka | Chief Commercial Officer | Feb 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 18, 2026 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2026 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2026 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2026 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2025 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2025 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2025 | Polly A. Murphy | Buy | 6,100 | $4.17 |
| May 18, 2025 | Polly A. Murphy | Buy | 6,100 | $4.17 |
AVIR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-158.35M | -1.94 | $-132.03M |
| Dec 31, 2024 | — | $-168.38M | -2.00 | $-135.50M |
| Dec 31, 2023 | — | $-135.96M | -1.63 | $-85.39M |
| Dec 31, 2022 | — | $-115.91M | -1.39 | $-120.98M |
| Dec 31, 2021 | $351.37M | $121.19M | 1.37 | $-87.00M |
Latest balance sheet: total assets $232.28M, total liabilities $39.78M, cash $76.55M (as of Jun 30, 2026).
AVIR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $5.06 |
| May 12, 2026 | 8-K Item 2.02 (results) | $5.50 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $5.30 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $3.61 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $3.50 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $3.46 |
| May 12, 2025 | 8-K Item 2.02 (results) | $2.96 |
| Apr 17, 2025 | 8-K Item 2.02 (results) | $2.97 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $3.00 |
| Jan 14, 2025 | 8-K Item 2.02 (results) | $3.15 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.44 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AVIR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.